Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219189 · ClinicalTrials.gov registry record · NA
The Acute Effect of Vaping on Food Intake
A NA study of E-Cig Use and Appetite, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04219189: Completed NA study of E-Cig Use and Appetite, sponsored by Virginia Commonwealth University.
NCT04219189 is a NA study of E-Cig Use and Appetite that has completed, run by Virginia Commonwealth University. The registered enrollment target is 40 participants, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04219189, a NA study of E-Cig Use and Appetite, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assesses the acute effects of a standardized 20-minute vaping episode compared to a non-vaping control condition on ad libitum food intake during a 30-minute buffet meal, occurring approximately 45 minutes after the vaping episode
Primary Outcome
Energy intake in kilocalories (kcal) during the ad libitum buffet meal will be measured via directly weighed food provision and waste (food/energy intake is calculated by difference).
Conditions Studied
Interventions
- OTHER Control condition
- OTHER Vaping condition
Study Locations (1)
Virginia
- Center for the Study of Tobacco Products - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2022-09-21 |
| Phase | NA |
What the finished NCT04219189 record still lists
NCT04219189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (73% lower).
The record links to 4 conditions, with E-Cig Use appearing as the primary indexed condition, and to 2 interventions - of which Control condition is the first listed.
NCT04219189 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04219189 about?
NCT04219189 is a clinical study titled "The Acute Effect of Vaping on Food Intake". This study assesses the acute effects of a standardized 20-minute vaping episode compared to a non-vaping control condition on ad libitum food intake during a 30-minute buffet meal, occurring approximately 45 minutes after the vaping episode
What is the current status of trial NCT04219189?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-09-22. Estimated completion is 2022-09-21.
What conditions does trial NCT04219189 study?
This clinical trial studies the following conditions: E-Cig Use, Appetite, Energy Intake, Food Intake.
What interventions are being tested in trial NCT04219189?
The interventions under investigation include: Control condition (OTHER), Vaping condition (OTHER).
Who is sponsoring clinical trial NCT04219189?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04219189 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E-Cig Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04219189's enrollment target sits among peer trials
40 9th of 9 higher than 1 of 9 other E-Cig Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other E-Cig Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BREATHE Free: a Pilot Feasibility Trial
RECRUITING · NA
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers
RECRUITING · NA
-
Respiratory Effects of E-Cigarettes in Obese Youth
ACTIVE NOT RECRUITING · NA
-
Media Literacy for High School Tobacco Prevention
COMPLETED · NA
-
The Impact of Chronic E-Cigarette Usage on Microvascular Health
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI